Lunit invites you to their event

AI in Mammography: Lunit INSIGHT MMG

About this event


Welcome to our Lunit AI webinar!

During this event you'll hear from multiple guest speakers on their experiences with AI in mammography. The speakers and their topics are as follows:


Dr. Hugh Harvey, Managing director at Hardian Health, United Kingdom.

  • Challenges in deploying AI in the NHS and how to overcome them


Dr. Anna Andreychenko and Dr. Tatiana Logunova , Senior and Junior Researchers, Head of Medical Informatics, Radiomics & Radiogenomics group Research and Practical Center of Medical Radiology, Department of Health Care of Moscow, Russia.

  • Results of a large scale, multi-medical center study of AI for Mammography involving 13 countries


Dr. Erkin Aribal, Radiology Professor at ACIBADEM University, Turkey (with support of Dr. Mustafa Ege Şeker)

  • Diagnostic performance of AI for cancers in mammography screening program


Mr. John Jong Seok Ahn, Medical Director at Lunit, South Korea.

  • Current and future plans of Lunit's AI solutions for mammography



πŸ“’ For further questions or a demo request, please click here.

πŸ“’ After you've watched it, visit our online demo website, insight.lunit.io.

Hosted by

  • Team member
    T
    John Jong Seok Ahn Medical Director @ Lunit Inc.

  • Guest speaker
    G
    Tatiana Logunova Radiologist @ Dept. of Healthcare - Moscow

  • Guest speaker
    G
    Anna Andreychenko Radiologist @ Dept. of Healthcare - Moscow

  • Guest speaker
    G
    Mustafa Ege Seker Researcher @ Acibadem

  • Team member
    T
    Team Lunit Lunit

  • Guest speaker
    G
    Erkin Aribal Professor of Radiology @ Acibadem

  • Guest speaker
    G
    Hugh Harvey Managing Director @ Hardian Health

Lunit

Conquer Cancer through AI

With an accuracy rate of 96-99%, our AI can empower you to achieve the highest level of accuracy in finding cancer and critical findings.

Lunit AI for chest x-ray and 2D & 3D mammography has been validated through 160+ studies and is now in use in over 2,300 sites globally.